---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-057950"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2021-11-10T23:59:59+00:00"
generated_at: "2026-06-28T09:49:39.132372+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx Q3 revenue up 53% to $16.1M; GAAP net income $0.04M

## Summary
- Revenue $16.1M (+53% YoY); brands on platform increased to 182 from 140.
- GAAP net income $0.04M ($0.00 EPS) vs loss of $0.3M YoY; non-GAAP net income $1.6M ($0.09 EPS).
- Gross margin 56.3% (slight decrease from 57.2%); cash $85M.
- RWE solution gaining traction; average client ROI 13:1.

## SEC filing metadata
- accession: 0001213900-21-057950
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2021-11-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000121390021057950/0001213900-21-057950-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000121390021057950/ea150273-8k_optimizerx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-057950
- JSON: https://secwatch.observer/filing/0001213900-21-057950.json
- Plain text: https://secwatch.observer/filing/0001213900-21-057950.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.